Sabby Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Sabby Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,768	Closed	-$126K	–	129
2022 Q4	$126K	Sell	8,768 -3,708	-30%	-$71.6K	0.11%	63
2022 Q3	$299K	Sell	12,476 -10,024	-45%	-$258K	0.38%	52
2022 Q2	$446K	Sell	22,500 -810	-3%	-$18K	0.3%	47
2022 Q1	$839K	Buy	23,310 +814	+4%	+$30.3K	0.13%	47
2021 Q4	$1.01M	Buy	22,496 +5,286	+31%	+$317K	0.15%	81
2021 Q3	$1.23M	Sell	17,210 -1,922	-10%	-$219K	0.17%	79
2021 Q2	$2.52M	Sell	19,132 -1,297	-6%	-$162K	0.36%	39
2021 Q1	$2.74M	Buy	+20,429	New	+$2.59M	0.53%	35

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Sabby Management's ASLN Position: Q1 2023 in Review

Sabby Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2023, closing a stake of 8,768 shares — an estimated $126K sold.

Sabby Management first reported a position in ASLN in Q1 2021 and held it in 8 quarters. The position peaked at $2.74M in Q1 2021. 16 funds tracked by Wall St. Rank hold ASLN as of Q1 2023.

Sabby Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Sabby Management sold 8,768 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2023, an estimated $126K.
Sabby Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 8 quarters.
Sabby Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $2.74M in Q1 2021.
16 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2023.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.